UPDATED: Federal Court Strikes Down Blue Cross Of Michigan's Denial Of Applied Behavior Analysis Therapy To Children With Autism
DETROIT, April 1, 2013 /PRNewswire/ -- The federal district court in Detroit held, on March 30, 2013, that Blue Cross Blue Shield of Michigan acted illegally in denying coverage for Applied Behavior Analysis ("ABA") therapy to children with autism spectrum disorder. The case is Potter, et al. v. Blue Cross Blue Shield of Michigan, Case No. 10-14981 (E.D. Mich., Hon. Stephen J. Murphy, III). The court, noting that ABA therapy is supported by numerous authorities, and is not supported by Blue Cross' own medical policy, held that Blue Cross' denial of insurance coverage for this therapy on the ground that that the therapy is "experimental" was arbitrary and capricious under federal law.
This ruling is expected to benefit over 500 children with autism spectrum disorder and result in over $5 million in ABA therapy benefits being paid to class members. In his ruling, Hon. Stephen J. Murphy, III held that "BCBS's medical policy [characterizing ABA therapy as "experimental"] is internally inconsistent, ambiguous, and, most fatally, not supported by the evidence in the record." The court granted the families' motion for judgment, declared Blue Cross' policy "arbitrary and capricious" under ERISA, overturned Blue Cross' denials of the families' claims for ABA coverage, and ordered Blue Cross to provide notice of the ruling to the families at Blue Cross' expense.
The court previously certified the case as a national class action, such that the case is on behalf of all similarly situated families covered by an ERISA health plan insured by or administered by Blue Cross, and who, at any time, were denied coverage for ABA therapy by Blue Cross on the ground that such therapy is allegedly "experimental" or "investigative," pursuant to Blue Cross' 2010 policy statement. Blue Cross attempted to overturn the court's initial class certification ruling in the Sixth Circuit Court of Appeals, but the Court of Appeals denied Blue Cross' Petition to Appeal in 2012.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV